Grace M. Lloyd

发表

Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Coeruleus Pathology and Nonmotor Features of Parkinson's Disease

Kirsten A. Porter-Stransky, M. Tansey, B. Giasson, 2020, The Journal of Neuroscience.

Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy

Nikolaus R. McFarland, N. McFarland, B. Giasson, 2021, Acta neuropathologica communications.

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease

S. Lincoln, N. Ertekin-Taner, B. Giasson, 2020, Acta Neuropathologica Communications.

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice

B. Giasson, Giavanna Paterno, S. Prokop, 2022, Acta Neuropathologica.

Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model

D. Borchelt, B. Giasson, Cara J. Riffe, 2021, Molecular Neurodegeneration.

Targeted proteolytic products of τ and α-synuclein in neurodegeneration

B. Giasson, Grace M. Lloyd, Yuxing Xia, 2021, Essays in biochemistry.

Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein

D. Dickson, B. Giasson, A. Yachnis, 2020, Neuroscience Letters.

Precision therapeutic targets for COVID-19

T. Golde, B. Giasson, D. Mitchell, 2021, Virology journal.

Precision therapeutic targets for COVID-19

T. Golde, B. Giasson, Grace M. Lloyd, 2021, Virology Journal.

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease

S. Lincoln, N. Ertekin-Taner, B. Giasson, 2020, Acta Neuropathologica Communications.

Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies

J. Trojanowski, B. Giasson, S. Prokop, 2021, Acta Neuropathologica Communications.

Proteinopathies and Neurotrauma: Update on Degenerative Cascades.

B. Lucke-Wold, S. Sriram, J. Figg, 2022, JSM neurosurgery and spine.

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis

D. Borchelt, B. Giasson, Zachary A. Sorrentino, 2023, Acta Neuropathologica Communications.

Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114

B. Giasson, Giavanna Paterno, S. Prokop, 2023, The Journal of biological chemistry.

Transgenic Mice Expressing Human a -Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson ’ s Disease

Kirsten A. Porter-Stransky, M. Tansey, B. Giasson, 2020 .

Transgenic Mice Expressing Human a -Synuclein in Noradrenergic Neurons Develop Locus Coeruleus Pathology and Nonmotor Features of Parkinson ’ s Disease

Kirsten A. Porter-Stransky, M. Tansey, B. Giasson, 2022 .

A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models

Giavanna Paterno, Zachary A. Sorrentino, Grace M. Lloyd, 2024, Acta neuropathologica communications.

Neuronal tissue collection from intra-cranial instruments used in deep brain stimulation surgery for Parkinson’s disease with implications for study of alpha-synuclein

Grace M. Lloyd, Rasheedat T Zakare-Fagbamila, D. Mampre, 2024, Scientific reports.